Aliases & Classifications for Gastroenteritis

MalaCards integrated aliases for Gastroenteritis:

Name: Gastroenteritis 12 76 55 43 44 15 73
Cholera Morbus 12 73
Infectious Colitis, Enteritis and Gastroenteritis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2326
ICD10 33 K52.9
MeSH 44 D005759
NCIt 50 C34632

Summaries for Gastroenteritis

MedlinePlus : 43 Have you ever had the "stomach flu?" What you probably had was gastroenteritis - not a type of flu at all. Gastroenteritis is an inflammation of the lining of the intestines caused by a virus, bacteria or parasites. Viral gastroenteritis is the second most common illness in the U.S. The cause is often a norovirus infection. It spreads through contaminated food or water, and contact with an infected person. The best prevention is frequent hand washing. Symptoms of gastroenteritis include diarrhea, abdominal pain, vomiting, headache, fever and chills. Most people recover with no treatment. The most common problem with gastroenteritis is dehydration. This happens if you do not drink enough fluids to replace what you lose through vomiting and diarrhea. Dehydration is most common in babies, young children, the elderly and people with weak immune systems. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

MalaCards based summary : Gastroenteritis, also known as cholera morbus, is related to eosinophilic gastroenteritis and acute pancreatitis, and has symptoms including abdominal cramps, abdominal pain and constipation. An important gene associated with Gastroenteritis is ANPEP (Alanyl Aminopeptidase, Membrane), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Fentanyl and Infliximab have been mentioned in the context of this disorder. Affiliated tissues include colon, testes and bone, and related phenotypes are immune system and digestive/alimentary

Disease Ontology : 12 A gastrointestinal system infectious disease that involves inflammation of the lining of the stomach and small and large intestines, which is caused by viruses, bacteria, or parasites. Chemicals and drugs also cause gastroenteritis. The symptoms include diarrhea, loss of appetite, nausea, vomiting, cramps, and discomfort in the abdomen.

Wikipedia : 76 Gastroenteritis, also known as infectious diarrhea, is inflammation of the gastrointestinal tract -- the... more...

Related Diseases for Gastroenteritis

Diseases related to Gastroenteritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 515)
# Related Disease Score Top Affiliating Genes
1 eosinophilic gastroenteritis 34.1 ALB CCL11 IL5 RNASE3
2 acute pancreatitis 30.7 CRP CXCL8 IL10 IL6
3 esophagitis 30.5 CCL11 CXCL8 IL1B IL5 IL6
4 duodenal ulcer 30.4 CXCL8 IL1B TNF
5 eosinophilic gastritis 30.4 CCL11 IL4 IL5
6 laryngitis 30.4 IL1B IL6 TNF
7 cystitis 30.2 CRP CXCL8 IL6 TNF
8 obstructive jaundice 30.2 ALB CXCL8 IL6 TNF
9 trichuriasis 30.2 CXCL8 IL10 TNF
10 diversion colitis 30.1 CDH1 IL1B IL4
11 milk allergy 30.0 IL10 IL4 IL5 RNASE3
12 crohn's disease 30.0 CRP IL10 IL1B IL6 TNF
13 eosinophilic pneumonia 29.8 CCL11 IL5 RNASE3
14 churg-strauss syndrome 29.8 IL10 IL5 RNASE3 TNF
15 proctitis 29.8 CRP RNASE3 TNF
16 sclerosing cholangitis 29.7 ALB FUT2 TNF
17 colitis 29.7 CXCL8 IFNG IL10 IL1B IL4 IL6
18 perinatal necrotizing enterocolitis 29.7 CRP CXCL8 IL1B IL6 TNF
19 cholangitis 29.7 ALB CRP FUT2 IL6 TNF
20 reactive arthritis 29.6 CRP IFNG IL10 IL6 TNF
21 listeriosis 29.6 CDH1 IL10 IL6 TNF
22 aspergillosis 29.5 IFNG IL10 IL4 IL5
23 bullous pemphigoid 29.4 CCL11 IL5 RNASE3
24 hypereosinophilic syndrome 29.3 CCL11 IFNA1 IL4 IL5 RNASE3
25 arthritis 29.2 CXCL8 IFNG IL10 IL1B IL6 TNF
26 celiac disease 1 29.2 ALB IFNG IL10 TNF
27 ulcerative colitis 29.1 CRP CXCL8 IL10 IL1B IL6 TNF
28 peritonitis 29.0 ALB CRP CXCL8 IL10 IL1B IL6
29 cytomegalovirus infection 29.0 CXCL8 IFNG IL10 IL6 TNF
30 food allergy 29.0 ALB IFNG IL10 IL4 IL5 RNASE3
31 graft-versus-host disease 28.9 IFNG IL10 IL1B IL6 TNF
32 helicobacter pylori infection 28.9 CXCL8 IFNG IL10 IL1B TNF
33 dermatitis 28.8 CCL11 IFNG IL4 IL5 RNASE3
34 bronchitis 28.8 ALB CCL11 CXCL8 IL5 RNASE3 TNF
35 severe acute respiratory syndrome 28.8 CXCL8 IFNA1 IFNG TNF
36 pyelonephritis 28.7 ALB CRP CXCL8 IL10 IL1B IL6
37 appendicitis 28.7 ALB CRP CXCL8 IL10 IL1B IL6
38 typhoid fever 28.6 ALB CRP IFNG IL1B IL6 TNF
39 skin disease 28.5 CXCL8 IFNG IL10 IL4 IL5 TNF
40 tonsillitis 28.5 CXCL8 IFNG IL1B IL4 IL6 TNF
41 salmonellosis 28.4 ALB IFNG IL1B LACTB
42 allergic asthma 27.9 CCL11 CXCL8 IFNG IL10 IL4 IL5
43 intestinal disease 27.8 ALB CRP CXCL8 IFNG IL10 IL1B
44 endocarditis 27.7 ALB CRP CXCL8 IL10 IL6 LACTB
45 rheumatoid arthritis 27.7 CRP CXCL8 IFNG IL10 IL1B IL4
46 systemic lupus erythematosus 27.4 ALB CRP IFNA1 IFNG IL10 IL4
47 multiple sclerosis 27.2 IFNA1 IFNG IL10 IL1B IL4 IL5
48 pneumonia 26.9 CCL11 CRP CXCL8 IL10 IL1B IL5
49 asthma 26.9 CCL11 CXCL8 IFNG IL10 IL1B IL4
50 bronchiolitis 26.9 CCL11 CXCL8 IFNG IL10 IL4 IL5

Graphical network of the top 20 diseases related to Gastroenteritis:



Diseases related to Gastroenteritis

Symptoms & Phenotypes for Gastroenteritis

UMLS symptoms related to Gastroenteritis:


abdominal cramps, abdominal pain, constipation, diarrhea, dyspepsia, fever, heartburn, icterus, nausea and vomiting, pruritus, signs and symptoms, digestive, gastric irritation, gastrointestinal gas

MGI Mouse Phenotypes related to Gastroenteritis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 10.15 IFNG IL6 IL10 TNF ANPEP IL1B
2 digestive/alimentary MP:0005381 10.06 IL10 TNF ALB IL4 CDH1 IL5
3 integument MP:0010771 9.92 IFNG IL6 IL10 IL1B ANPEP IL4
4 liver/biliary system MP:0005370 9.8 IFNG IL6 IL10 ALB IL4 TNF
5 neoplasm MP:0002006 9.76 IFNG IL6 IL10 TNF ALB IL1B
6 reproductive system MP:0005389 9.61 IFNG IL6 IL10 ANPEP IL4 CDH1
7 respiratory system MP:0005388 9.17 IFNG IL6 IL10 CCL11 IL4 IL5

Drugs & Therapeutics for Gastroenteritis

Drugs for Gastroenteritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 793)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 437-38-7 3345
2
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 170277-31-3
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
4
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 1400-61-9 11953884
5
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 50-23-7 5754
6
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 53-03-2 5865
7
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 428863-50-7
8
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
11
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 26787-78-0 33613
12
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 85721-33-1 2764
13
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 443-48-1 4173
14
Azathioprine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 446-86-6 2265
15
Ceftriaxone Approved Phase 4,Not Applicable 73384-59-5 5479530 5361919
16
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
17
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
18
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
19
Clarithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81103-11-9 84029
20
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 117976-89-3 5029
21
Clofazimine Approved, Investigational Phase 4,Phase 3 2030-63-9 2794
22
Rifabutin Approved, Investigational Phase 4,Phase 3 72559-06-9 6323490
23
Ertapenem Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 153832-46-3 150610
24
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 138530-94-6, 103577-45-3 9578005
25
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 103577-45-3 3883
26
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
27
Metoclopramide Approved, Investigational Phase 4,Phase 3,Not Applicable 364-62-5 4168
28
Ondansetron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 99614-02-5 4595
29
Loperamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53179-11-6 3955
30
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 7440-66-6 23994
31
Zinc sulfate Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 7733-02-0
32
Calcium Carbonate Approved, Investigational Phase 4,Not Applicable 471-34-1
33
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
34
Menthol Approved Phase 4,Phase 1,Phase 2,Not Applicable 2216-51-5 16666
35
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 2078-54-8 4943
36
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 73590-58-6 4594
37
Rosiglitazone Approved, Investigational Phase 4,Phase 1,Phase 2 122320-73-4 77999
38
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 161796-78-7, 119141-88-7 4594 9579578
39
Sucralfate Approved Phase 4,Phase 3,Early Phase 1 54182-58-0 0
40
Hydroxocobalamin Approved Phase 4,Phase 2 13422-51-0 11953898 44475014
41
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 57-27-2 5288826
42
Budesonide Approved Phase 4,Phase 3,Phase 2,Not Applicable 51333-22-3 63006 5281004
43
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
44
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7439-89-6 23925
45
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 90566-53-3 62924
46
Ropivacaine Approved Phase 4,Phase 1,Phase 2,Not Applicable 84057-95-4 71273 175805
47
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148-82-3 4053 460612
48 Vedolizumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 943609-66-3
49
Glycerol Approved, Investigational Phase 4,Phase 3,Phase 2 56-81-5 753
50
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-02-2 5743

Interventional clinical trials:

(show top 50) (show all 3257)
# Name Status NCT ID Phase Drugs
1 Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis Unknown status NCT02508142 Phase 4 Hyoscine-N-Butylbromide
2 Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab Unknown status NCT02453776 Phase 4 PRECISION dosing Infliximab
3 Withholding Feeds During Red Blood Cell Transfusion and TRAGI Unknown status NCT02132819 Phase 4
4 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
5 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
6 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
7 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
8 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
9 Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult Unknown status NCT02056418 Phase 4 corticosteroid
10 Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission Unknown status NCT01817426 Phase 4 Infliximab
11 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Unknown status NCT01632462 Phase 4 VSL#3
12 Optimizing Cimzia in Crohn's Patients Unknown status NCT01024647 Phase 4
13 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
14 Evaluation of PET CT in the Management of Patients With Crohn's Disease. Unknown status NCT00731809 Phase 4
15 Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Unknown status NCT00609752 Phase 4 prednisolone
16 VSL#3 Treatment in Children With Crohn's Disease Unknown status NCT00367705 Phase 4
17 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
18 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Unknown status NCT00265772 Phase 4 MODULEN IBD (R) (specific Enteral Nutrition);prednisolon
19 A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis Unknown status NCT02425852 Phase 4 Azathioprine;Infliximab;Prednisolone;Hydrocortisone
20 Prucalopride Prior to Small Bowel Capsule Endoscopy Unknown status NCT02806206 Phase 4 Prucalopride;Placebo
21 The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis Unknown status NCT01278017 Phase 4 ceftriaxone
22 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
23 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
24 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
25 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
26 Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe Unknown status NCT01630096 Phase 4 Nu-Lytely
27 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
28 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Unknown status NCT00513552 Phase 4 Rifabutin, Clarithromycin, and Clofazimine
29 Antibiotics Versus Surgery in Acute Appendicitis Unknown status NCT01421901 Phase 4 Ertapenem
30 Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis Unknown status NCT02759393 Phase 4 Dexlansoprazole;Lansoprazole
31 Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis Unknown status NCT00097734 Phase 4 ertapenem
32 Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. Completed NCT00740935 Phase 4
33 Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis Completed NCT01165866 Phase 4 Treatment 1. Metoclopramide;Treatment 2 Ondansetron
34 Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis Completed NCT02025452 Phase 4
35 A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis Completed NCT00124787 Phase 4 Dimenhydrinate;Placebo
36 Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis Completed NCT00392145 Phase 4 Standard IV rehydration;Rapid intravenous rehydration (RIVR)
37 Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis Completed NCT01467570 Phase 4
38 Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis Completed NCT01657032 Phase 4
39 Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan Completed NCT01870635 Phase 4 Ondansetron;Placebo
40 Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan Completed NCT01870648 Phase 4 Ondansetron;Placebo
41 Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants Completed NCT00779779 Phase 4
42 Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children Completed NCT02169817 Phase 4 Bacillus clausii;Oral Rehydration Therapy
43 Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab Completed NCT00737503 Phase 4
44 Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour Completed NCT01398696 Phase 4
45 Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana Completed NCT01575197 Phase 4
46 Immunogenicity of Rotavirus Vaccine Completed NCT01199874 Phase 4
47 An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) Completed NCT01960725 Phase 4
48 The Treatment Effect of Bio-Three on Children With Enteritis Completed NCT01480947 Phase 4 Bio-three
49 Efficacy of Racecadotril in Acute Watery Diarrhea in Children Completed NCT01577043 Phase 4 Racecadotril
50 Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants Completed NCT01571856 Phase 4 Zinc Sulfate

Search NIH Clinical Center for Gastroenteritis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: gastroenteritis

Genetic Tests for Gastroenteritis

Anatomical Context for Gastroenteritis

MalaCards organs/tissues related to Gastroenteritis:

41
Colon, Testes, Bone, T Cells, Kidney, Small Intestine, Bone Marrow

Publications for Gastroenteritis

Articles related to Gastroenteritis:

(show top 50) (show all 1168)
# Title Authors Year
1
Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry. ( 29879540 )
2018
2
A Case of Eosinophilic Gastroenteritis in Which Obstructive Jaundice Developed due to Invagination of the Duodenal Wall. ( 29434146 )
2018
3
Accuracy of pediatric residents in determination of dehydration in children with gastroenteritis. ( 29881534 )
2018
4
Pilot survey of norovirus in Northern Italy: an example of surveillance of norovirus gastroenteritis. ( 29307329 )
2018
5
Acute gastroenteritis in a pediatric population from Cali, Colombia in the post rotavirus vaccine era. ( 29908961 )
2018
6
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy. ( 29438743 )
2018
7
An unusual outbreak of rotavirus G8P[8] gastroenteritis in adults in an urban community, Singapore, 2016. ( 29902679 )
2018
8
Acute gastroenteritis: evidence-based management of pediatric patients. ( 29369591 )
2018
9
Characterization of a Vesivirus Associated with an Outbreak of Acute Hemorrhagic Gastroenteritis in Domestic Dogs. ( 29444830 )
2018
10
Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis. ( 29596982 )
2018
11
Hospital care for viral gastroenteritis in socio-economic and geographical context in Sweden 2006-2013. ( 29863748 )
2018
12
Eosinophilic gastroenteritis presenting with gastric perforation. ( 29366927 )
2018
13
Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015. ( 29907481 )
2018
14
Transmissible gastroenteritis virus N protein causes endoplasmic reticulum stress, up-regulates interleukin-8 expression and its subcellular localization in the porcine intestinal epithelial cell. ( 29909129 )
2018
15
Successful Food-Elimination Diet in an Adult with Eosinophilic Gastroenteritis. ( 29850645 )
2018
16
New viruses associated with canine gastroenteritis. ( 29428093 )
2018
17
Draft Genome Sequences of Two<i>Vibrio parahaemolyticus</i>Strains Associated with Gastroenteritis after Raw Seafood Ingestion in Colorado. ( 29348331 )
2018
18
Ascites in a Young Woman: A Rare Presentation of Eosinophilic Gastroenteritis. ( 29862093 )
2018
19
The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children. ( 29391385 )
2018
20
Efficacy and Safety of Fixed Dose Combination of Drotaverine Hydrochloride (80 mg) and Paracetamol (500 mg) in Amelioration of Abdominal Pain in Acute Infectious Gastroenteritis: A Randomized Controlled Trial. ( 29968385 )
2018
21
Acute gastroenteritis: evidence-based management of pediatric patients [digest]. ( 29388753 )
2018
22
Diarrheagenic Escherichia Coli and Acute Gastroenteritis in Children in Davidson County, Tennessee, United States: A Case-Control Study. ( 29341983 )
2018
23
Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment. ( 29476289 )
2018
24
Afebrile Benign Convulsion Associated With Mild Gastroenteritis: A Cohort Study in a Tertiary Children Hospital. ( 29881767 )
2018
25
Genomic characterization of circoviruses associated with acute gastroenteritis in minks in northeastern China. ( 29948383 )
2018
26
Eosinophilic Gastroenteritis and Colitis: Not Yet Ready for the Big Leagues. ( 29620603 )
2018
27
Two Gastroenteritis Outbreaks Caused by Sapovirus in Shenzhen, China. ( 29882310 )
2018
28
A life-devastating cause of gastroenteritis in an immunocompetent host: was it suspected? ( 29375867 )
2018
29
A foodborne acute gastroenteritis outbreak caused by GII.P16-GII.2 norovirus in a boarding high school, Beijing, China: a case-control study. ( 29970134 )
2018
30
Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( 29306004 )
2018
31
Takayasu's arteritis associated with eosinophilic gastroenteritis, possibly via the overactivation of Th17. ( 29942355 )
2018
32
Rapid intravenous rehydration of children with acute gastroenteritis and dehydration: a systematic review and meta-analysis. ( 29426307 )
2018
33
Relationship between Enteric Pathogen and Acute Gastroenteritis Disease Severity - A Prospective Cohort Study. ( 29964235 )
2018
34
Efficacy of Single Administration of High-dose Phenobarbital Suppository as Initial Therapy for Benign Infantile Convulsions with Mild Gastroenteritis. ( 29900149 )
2018
35
Evaluation of a New Multiplex Real-Time PCR Assay for Detecting Gastroenteritis-Causing Viruses in Stool Samples. ( 29401556 )
2018
36
Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo. ( 29397224 )
2018
37
Household transmission of acute gastroenteritis during the winter season in Japan. ( 29865912 )
2018
38
Eosinophilic gastroenteritis: An unusual presentation of a rare disease. ( 29555104 )
2018
39
Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections. ( 29932149 )
2018
40
Clinical outcome of recurrent afebrile seizures in children with benign convulsions associated with mild gastroenteritis. ( 29935410 )
2018
41
Complete Genome Sequence of a Novel Recombinant GII.P16-GII.1 Norovirus Associated with a Gastroenteritis Outbreak in Shandong Province, China, in 2017. ( 29439040 )
2018
42
Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values. ( 29908252 )
2018
43
Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. ( 29533199 )
2018
44
Norovirus in feces and nasopharyngeal swab of children with and without acute gastroenteritis symptoms: First report of GI.5 in Brazil and GI.3 in nasopharyngeal swab. ( 28033513 )
2017
45
Comparison of three multiplex gastrointestinal platforms for the detection of gastroenteritis viruses. ( 28889082 )
2017
46
Eosinophilic gastroenteritis caused by eating hens' eggs: A case report. ( 28279648 )
2017
47
Targeted anthelmintic treatment of parasitic gastroenteritis in first grazing season dairy calves using daily live weight gain as an indicator. ( 28917324 )
2017
48
Case of bullous pemphigoid accompanied by collagenous gastroenteritis. ( 28862318 )
2017
49
Red palms associated with adenovirus gastroenteritis. ( 28082320 )
2017
50
Eosinophilic gastroenteritis presenting as upper gastrointestinal hematoma and ulcers after endoscopic biopsy: A case report and literature review. ( 28906408 )
2017

Variations for Gastroenteritis

Expression for Gastroenteritis

Search GEO for disease gene expression data for Gastroenteritis.

Pathways for Gastroenteritis

Pathways related to Gastroenteritis according to GeneCards Suite gene sharing:

(show top 50) (show all 67)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.1 ANPEP CCL11 CDH1 CRP CXCL8 IFNA1
2
Show member pathways
13.75 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
3
Show member pathways
13.59 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
4
Show member pathways
13.46 CCL11 CXCL8 IL10 IL1B IL4 IL5
5
Show member pathways
13.46 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
6
Show member pathways
13.39 CCL11 CDH1 CXCL8 IL10 IL1B IL4
7
Show member pathways
13.1 CXCL8 IFNA1 IFNG IL10 IL1B IL6
8 12.94 CDH1 CXCL8 IFNA1 IFNG IL4 IL5
9
Show member pathways
12.9 CXCL8 IFNA1 IFNG IL1B IL4 IL6
10
Show member pathways
12.85 CXCL8 IFNA1 IFNG IL1B IL6 TNF
11
Show member pathways
12.74 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
12 12.67 IFNA1 IFNG IL10 IL1B IL4 TNF
13
Show member pathways
12.65 IFNG IL10 IL1B IL6 TNF
14
Show member pathways
12.57 IFNG IL10 IL1B IL4 IL5 IL6
15
Show member pathways
12.57 CXCL8 IFNA1 IFNG IL10 IL1B IL4
16
Show member pathways
12.55 IFNG IL10 IL1B IL4 IL5 IL6
17
Show member pathways
12.45 ALB CRP IFNG IL1B IL4 IL6
18
Show member pathways
12.39 CCL11 CXCL8 IFNG IL1B IL4 IL5
19
Show member pathways
12.38 CXCL8 IFNG IL1B IL6 TNF
20
Show member pathways
12.37 IFNG IL10 IL1B IL6 TNF
21
Show member pathways
12.36 IFNG IL10 IL1B IL4 TNF
22 12.36 IFNA1 IFNG IL10 IL1B IL6 TNF
23 12.29 CXCL8 IL10 IL1B IL6 TNF
24
Show member pathways
12.29 CCL11 CXCL8 IFNG IL1B IL4 IL6
25
Show member pathways
12.28 CXCL8 IL1B IL6 TNF
26
Show member pathways
12.27 IL10 IL1B IL6 TNF
27
Show member pathways
12.27 IFNA1 IFNG IL1B TNF
28 12.25 CDH1 IFNG IL6 TNF
29
Show member pathways
12.16 CCL11 CDH1 CXCL8 IFNG IL10 IL1B
30 12.15 CXCL8 IFNG IL1B IL4 IL6 TNF
31 12.09 ANPEP IFNG IL10 IL4 IL5 IL6
32 12.03 CXCL8 IFNG IL1B IL6
33 12.03 ANPEP IL1B IL4 IL5 IL6 TNF
34 12.03 CCL11 CXCL8 IL10 IL1B IL4 IL6
35 12.02 CXCL8 IFNG IL10 IL1B IL6 TNF
36 12 CXCL8 IL1B IL6 TNF
37 12 CXCL8 IFNG IL1B IL6 TNF
38 11.96 IFNA1 IFNG IL10 IL6
39 11.95 CXCL8 IFNG IL4 IL5 IL6
40 11.93 CXCL8 IFNG IL1B IL6
41 11.92 IFNG IL10 IL1B IL4 IL5 TNF
42
Show member pathways
11.91 CXCL8 IFNG IL4 IL5 TNF
43 11.9 CXCL8 IL10 IL1B IL6 TNF
44 11.89 CXCL8 IL1B TNF
45 11.86 CDH1 IFNG IL10 IL1B IL6 TNF
46
Show member pathways
11.81 CXCL8 IFNG IL1B IL6 TNF
47 11.79 CCL11 IL10 IL4 IL5
48 11.72 CXCL8 IL1B IL6 TNF
49 11.65 CXCL8 IFNG IL6
50 11.64 CCL11 IFNG IL10 IL4 IL5

GO Terms for Gastroenteritis

Cellular components related to Gastroenteritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.8 ALB CCL11 CDH1 CRP CXCL8 IFNA1
2 extracellular space GO:0005615 9.47 ALB ANPEP CCL11 CRP CXCL8 IFNA1

Biological processes related to Gastroenteritis according to GeneCards Suite gene sharing:

(show all 35)
# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.86 CCL11 CRP CXCL8 IL10 IL1B IL5
2 cellular response to lipopolysaccharide GO:0071222 9.85 CXCL8 IL10 IL6 TNF
3 B cell differentiation